Member Info for lofas

On the other hand we know:
BioNTech collaboration and ongoing interest.
Merck’s predicament, wants to grow the KEYTRUDA market and will require Scancell toolbox to do so.
Prof LD was taken by surprise when they review the initial results from clinic
Prof LD acknowledged she will get into trouble, hence not much she could divulge during last SH meeting
Ex Chairman golden nuggets acknowledgment.
Various ongoing collaborations
Exclusive patents
Up front payments
And all of that + others at fully diluted 1B shares @25p is £250m…regardless tomorrow’s update we need to wait for the real update, how outstanding the golden nuggets are.

Ditto. Not expecting much…SP will probably slide as a result, so will be ready to pick some up.

@chester
Moving away from this annoying level. Hope we can be up soon.

Waiting for the 25th but to be honest don’t expect much outside the interim scope. No breaking news maybe upfront cash payment in a good case scenario.

Ditto. Never voted red… but to be honest very little works in UK. Conservative in power for the last 12years, they lost their way and about time to hand over the keys…but to who ? Angela &Co…G-d help us.

We hope for big news to become public sometime soon, however how soon and whether that will be before interim is not clear at all.

WF, TK thanks for the feedback. It is strange , the focus on mRNA, as if the golden nuggets are not golden at all.

Is this somehow connected to Scancell ?

Genmab was mentioned in the interview, pointing out that 6 folks were on the payroll 20 years ago. Now $20B market value…although I don’t have enough of it, I keep telling myself that patience is key to avoid mistakes. As always SC update is talk we are waiting for , the rest walks.

Golden nuggets are selling for £10 a piece , if one would like the entire combo deal then £20 is a very sensible prediction. Prof LD wrote an entire email as suppose to 3 lines and that goes back to 2011. In addition , they were amazed with what the saw/see in clinic. Modi is the golden nugget modi-2 may outperform, so much to wait for…

Moditop discovery 11 years ago
In clinic it appears that response is similar across all cohort participants , however in line with previous RNS only confirmation in cancer reduction for lady X.
One day the email sent by LD will become a museum exhibit…wow.

Horses with CAR T-cell efficacy result update. Winner winner front line winner.

Ditto, SC update is the only talk the rest walks.

Commercialisation???
SC is 40 folks company there is a limit to what these brilliant limited amount of folks can do. Don’t think giants like Mercks and others will wait. That is why I think deal must be to wrap it up….IMHO

Yes Crumbs…gazillions.

No no $10B, £10B.
If SC does what we hope , melting cancer and give life for folks where KETRUDA doesn’t touch it , then yes.

As far ad Merck and providing SC does what we think it is….should be £10B deal for the entire SC tool box. We will have to wait for descent offers from others.

Re : Merck…already regurgitated from possible directions. Same for BioNTech in relation to SC.
Mind you , sone folks did not view the Merck interview as breaking news. So far it’s yesterday’s news and we are still waiting for LD’s update.

How this help us?

Brilliant.